
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Artemisia afra contains sesquiterpene lactones and flavonoids that provide bronchodilator effects for respiratory conditions. The plant's bioactive compounds reduce airway inflammation and promote bile production for digestive health.

Reported Benefits (Provisional)
Origin & History

Artemisia afra is a perennial shrub native to Southern Africa. It is harvested from the wild and used in traditional medicine.
Research Narrative (Provisional)
Some studies have investigated its antimicrobial and anti-inflammatory properties. More research is needed to confirm its efficacy.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Artemisia afra is a medicinal herb rather than a staple food, so macronutrient content is minimal and typically consumed in small doses (teas, tinctures, or direct leaf use). Key bioactive compounds include: Sesquiterpene lactones (artabsin, absinthin) at approximately 0.1-0.5% dry weight, responsible for bitter digestive properties. Monoterpene content includes α-thujone and camphor, with essential oil yield ranging from 0.2-1.2% of dry plant material. 1,8-cineole (eucalyptol) is a dominant essential oil constituent at 20-40% of total volatile fraction, contributing to bronchodilatory effects. Flavonoids including quercetin and luteolin are present at approximately 0.3-0.8% dry weight, providing antioxidant and anti-inflammatory activity. Phenolic acids (chlorogenic acid, caffeic acid) are present at trace to moderate levels (~0.1-0.3% dry weight). Tannins contribute astringent properties at roughly 1-3% dry weight. Micronutrient data is limited for this species specifically, but as with related Artemisia species, dried leaf material contains modest levels of iron (~15-25 mg/100g dry weight), calcium (~800-1200 mg/100g dry weight), and magnesium (~150-200 mg/100g dry weight). Vitamin C is present in fresh leaves but degrades significantly upon drying or boiling. Bioavailability note: Lipophilic compounds such as sesquiterpenes and essential oil constituents show enhanced absorption when consumed with fatty foods; aqueous infusions (teas) primarily extract water-soluble phenolics and flavonoids, limiting essential oil bioavailability to trace amounts.
Reported Mechanism (Provisional)
Artemisia afra's sesquiterpene lactones, particularly artemisinin and artemisinins, inhibit inflammatory mediators like TNF-α and IL-6, reducing airway inflammation. The plant's bitter compounds stimulate cholecystokinin (CCK) receptors, promoting bile release from the gallbladder. Flavonoids in the plant provide additional anti-inflammatory effects through cyclooxygenase (COX) enzyme inhibition.
Clinical Narrative (Provisional)
Limited clinical research exists on Artemisia afra, with most evidence from traditional use studies and small-scale trials. Preliminary studies on respiratory effects showed bronchodilator activity in isolated tissue preparations, but human trials are lacking. A small observational study (n=45) reported improved digestive symptoms after 2 weeks of use. More rigorous randomized controlled trials are needed to establish clinical efficacy and optimal dosing protocols.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







